benazepril (Briem)

Subscribe to Selected New Research on benazepril

207 relevant articles (45 outcomes, 67 trials/studies) found for this Drug

Description: structure given in first source

Also Known As:

Briem; Lotensin; Beecham brand of benazepril hydrochloride; CGS-14824-A; CGS-14824A; Cibacen; Cibacène; Labopal; Novartis brand of benazepril hydrochloride; Pierre Fabre brand of benazepril hydrochloride; benazapril; benazepril hydrochloride; benzazepril; 1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(R*,R*))-

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

2-Ring Heterocyclic Compounds

Benzazepines: 2

benazepril: 207

Experts

1.	Watanabe, Toshifumi: 3 articles (05/2008 - 09/2006)
2.	Mishina, Mika: 2 articles (05/2008 - 10/2007)
3.	Xie, Di: 2 articles (06/2007 - 01/2006)
4.	Zhang, Xun: 2 articles (06/2007 - 01/2006)
5.	Jiang, Jian Ping: 2 articles (06/2007 - 01/2006)
6.	Liang, Min: 2 articles (06/2007 - 01/2006)
7.	Zhang, Wei Ru: 2 articles (06/2007 - 01/2006)
8.	Hou, Fan Fan: 2 articles (06/2007 - 01/2006)
9.	Chen, Ping Yan: 2 articles (06/2007 - 01/2006)
10.	Nakano, Masakazu: 2 articles (09/2006 - 06/2003)

Related Diseases

1.	Hypertension (High Blood Pressure) 03/01/2001 - "Administration of benazepril was also associated with a small but significant reduction in degree of systemic hypertension and an increase in whole kidney GFR" 03/01/1998 - "Study showed that benazepril in a dose range of 10 to 20 mg per day is an effective agent for treatment of mild to moderate hypertension." 03/01/1994 - "The aim of the study was to evaluate efficacy of benazepril prescribed as replacement therapy in patients with mild to moderate hypertension, according to the pharmacological class of the previous unsuccessful drug" 01/01/1998 - "Antihypertensive action and predictive factors of efficacy of benazepril in mild-to-moderate hypertension: clinical trial in general medical practice on 16,987 patients]" 09/08/1996 - "Efficacy of benazepril monotherapy in moderate essential hypertension studied by automatic ambulatory blood pressure monitoring]" Order ALL the reference details at left...
2.	Proteinuria 01/01/1993 - "In conclusion, the results of this study suggest that proteinuria in the nephrotic range does not require a change in benazepril dosage." 09/01/2006 - "In conclusion, benazepril decreased proteinuria in cats with CKD." 01/12/2006 - "Benazepril therapy was associated with a 52 percent reduction in the level of proteinuria and a reduction of 23 percent in the rate of decline in renal function" 01/01/1993 - "Proteinuria was diminished after benazepril in 7 patients" 01/01/1993 - "We have investigated whether the pharmacokinetics and pharmacodynamics of the ACE inhibitor benazepril hydrochloride are altered with proteinuria by studying 8 patients with major proteinuria of different causes who were given a single dose of 10 mg p.o" Order ALL the reference details at left...
3.	Heart Failure 02/01/1993 - "The purpose of this study was to examine the sequential changes in renal and cardiovascular function produced by chronic Benazepril administration at different stages of heart failure in dogs" 08/01/1992 - "The Benazepril Heart Failure Study Group." 12/01/1990 - "In this study, 21 patients with New York Heart Association Class III or IV congestive heart failure were treated with 2 to 15 mg of benazepril HCl as a single daily oral dose for 28 days to determine the clinical and hemodynamic value of chronic therapy" 12/01/1990 - "Previous studies have shown benazepril to lower blood pressure in hypertensive patients and to confer acute hemodynamic benefits in patients with congestive heart failure (CHF)" 03/01/1993 - "Reduction of exercise-induced ventricular arrhythmias in mild symptomatic heart failure by benazepril." Order ALL the reference details at left...
4.	Renal Insufficiency 04/11/1996 - "Benazepril provides protection against the progression of renal insufficiency in patients with various renal diseases." 01/01/2008 - "Chinese prospective clinical trials showed that benazepril (BZ) conferred substantial renal benefits in patients with advanced renal insufficiency" 10/01/1996 - "In AIPRI trial (ACE-inhibition in the progression of renal insufficiency) the ACE-inhibitor benazepril was able to protect patients with mild-to-moderate renal disease against the progression of renal insufficiency" 04/11/1996 - "In a three-year trial involving 583 patients with renal insufficiency caused by various disorders, 300 patients received benazepril and 283 received placebo" 05/01/2006 - "Efficacy and safety of benazepril for advanced renal insufficiency." Order ALL the reference details at left...
5.	Chronic Renal Insufficiency 09/01/2006 - "Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats." 01/01/2002 - "PATIENTS AND INTERVENTIONS: In the clinical studies on which this economic analysis was based, patients with chronic renal insufficiency of various aetiologies were randomised to antihypertensive therapy with or without concomitant benazepril" 12/01/1997 - "A prospective, randomized, double-blind trial recently demonstrated that treating patients with chronic renal insufficiency with benazepril significantly decelerates the rate of progression of the disease" 04/06/2006 - "Benazepril for advanced chronic renal insufficiency." 04/06/2006 - "Benazepril for advanced chronic renal insufficiency." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
2.	Amlodipine (Norvasc)
3.	Hydrochlorothiazide (Esidrix)
4.	valsartan (Vals)
5.	Creatinine
6.	Captopril (Capoten)
7.	Calcium Channels (Calcium Channel)
8.	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
9.	Losartan (Cozaar)
10.	Metoprolol (Lopressor)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Ligation
3.	Nephrectomy
4.	Angioplasty (Angioplasties)
5.	Surgical Instruments (Clip)

Best Treatments:
Research Summary Report
on Hypertension

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3762 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>